Getting your player ready...
WASHINGTON — Acknowledging that the development of medical countermeasures against bioterror threats and pandemic flu is lagging, federal authorities Thursday announced a $1.9 billion makeover of the system for identifying and manufacturing drugs and vaccines for public health emergencies.
The overhaul includes manufacturing refinements aimed at shaving weeks off the time it takes to produce pandemic flu vaccine and a series of steps to speed the spotting of scientific discoveries and getting them to market.
